An individualized comprehensive care package for acute exacerbation of chronic obstructive pulmonary disease patients reduces 90-day mortality.
Although a “need-based” individualized comprehensive care package for people admitted to hospitals for acute exacerbation of chronic obstructive pulmonary disease (COPD) did not reduce 30- and 90-day readmission rates in all patients, it did reduce 90-day total mortality and also reduced 90-day readmission rates in women. The study, by Simon L. Adamson, and colleagues, was published in the International Journal of COPD.
Acute exacerbation of COPD, characterized by a sudden worsening of patients’ respiratory symptoms, such as shortness of breath, cough, and sputum production, is associated with increased COPD morbidity and mortality. Acute exacerbation of COPD also decreases quality of life, accelerates lung function decline, and is associated with significant healthcare costs. Since patients with COPD experience the greatest number of readmissions to acute hospital care and the emergency department of any patient group, reducing acute exacerbation of COPD and reducing hospital readmissions are primary goals of COPD management.
The authors retrospectively reviewed data of patients admitted for acute exacerbation of COPD to 2 inner-city teaching hospitals to determine the impact of a comprehensive and individualized care management strategy on readmissions for acute exacerbation of COPD. The experimental group (191 patients) received comprehensive care targeted to the sensitive time period (2-4 weeks) immediately following a hospitalization due to acute exacerbation of COPD; 271 patients were controls. The total number of readmissions in 30 and 90 days after index hospitalization were measured, and the length of time between index admission and first readmission and all-cause mortality were secondary outcomes.
The 2 groups were similar in terms of age, sex, forced expiratory volume in 1 second, body mass index, pack-years smoked, and number and types of comorbidities. Comprehensive care significantly reduced 90-day readmission rates in females (P = .0205) but not in males or in the whole group. Average times between index admission and first readmission were not different between the 2 groups. The 90-day all-cause in-hospital mortality rates were significantly less in the care package group (2.67% vs 7.97%, P = .0268).
A larger randomized trial is needed to tease out which aspects of the comprehensive plan are more effective in improving patient outcomes, the authors note.
“We suspect that better and earlier recognition of exacerbations, improved self-management techniques, and availability of an outreach team in the community could have contributed to the beneficial effects of the intervention after [acute exacerbation of] COPD,” they concluded.
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More